The client in this program is a medium sized biotech with ongoing big pharma collaborations. They have an internal team of medicinal chemists but were looking for increased chemistry bandwidth. The company has its own internal biology which they were keen to maintain.

The client in this program is a small biotech with a limited internal chemistry capacity. They have taken an IP position across a privileged structure that can be used as an isostere in a number of marketed API’s.

The client in this program is a virtual biotech with no internal chemistry capacity. They have a clinical candidate which is protected by a use patent on a target but were looking to develop a back-up compound in clear IP space.

The client in this program is a medium sized biotech with no internal chemistry capacity. Working from a few early hit compounds, the project involved lead generation, optimization and ultimately, selection of a development candidate.

The client in this program was a small biotech with minimal internal chemistry and a long standing contract with a biology CRO.